by editor | Mar 25, 2015 | Clinicians, Participants, Researchers
A recent report that an individual’s genetic make-up could determine whether aspirin had a positive or negative effect on colorectal (bowel) cancer, is inconclusive said a leading cancer researcher and oncologist, Professor Peter Gibbs. Above: Prof Peter Gibbs is a...
by editor | Oct 20, 2014 | Clinicians, Participants, Researchers
Possible mechanisms of aspirin discussed ANNOUNCEMENT Melbourne, 20 October 2014: The use of aspirin to prevent cancer will be discussed by experts at a symposium in Melbourne today. Leading healthcare professionals will discuss the scientific evidence for...
by editor | Aug 7, 2014 | Clinicians, Participants, Researchers
Lack of data underscores importance of ASPREE trial A large scientific review revealed that aspirin protected people aged 50-65 against gastrointestinal cancer, but was unable to determine cancer benefits for those aged over 70. International researchers, who analysed...
by editor | Jul 22, 2013 | Clinicians, Participants, Researchers
Not conclusive – seek medical advice first says ASPREE investigator Healthy people of all ages should consult their GP prior to commencing aspirin for disease prevention. That’s the advice from Professor Mark Nelson in response to new research that...
by editor | Mar 12, 2013 | Clinicians, Participants, Researchers
Highlights the need for a clinical trial says Oncologist Medical Oncologist Dr Andrew Haydon, who works on cancer aspects of ASPREE, said that a recent association between aspirin and a reduced risk of developing melanoma, was a call for closer investigation of...
Recent Comments